Sym013 (Pan-HER)

Pan-HER · Symphogen A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sym013 (Pan-HER), covering 2020-08-28 to 2020-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies [Phase 1, Phase 2]